Stay updated on Phase 2a Safety of MEDI8852 in Influenza Clinical Trial

Sign up to get notified when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” terminology is no longer displayed. The page continues to show a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-11-08T06:26:18.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T04:24:54.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A notice announces an NIH transition update, including a statement that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T06:24:20.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer site revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T05:11:35.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T08:15:05.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record, indicating access to the record is blocked at this time.
    Difference
    18%
    Check dated 2026-09-20T03:53:21.000Z thumbnail image

Stay in the know with updates to Phase 2a Safety of MEDI8852 in Influenza Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.